Colon Cancer
Colorectal Cancer: A Phase 2, Randomized, Open-Label Study Comparing Telisotuzumab Adizutecan (ABBV-400) Monotherapy to the Current Standard of Care in Subjects with Post Adjuvant ctDNA Positive Colorectal Cancer and No Radiographic Evidence of Disease (NED) (M24-534)
- Details
ClinicalTrials.gov ID:
NCT07023289
Diagnosis Type:
NA
USOR Number:
- Address
,
P: